Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Operating Income: 2018-2022

Historic Operating Income for ADC Therapeutics (ADCT) over the last 5 years, with Dec 2022 value amounting to -$123,627.

  • ADC Therapeutics' Operating Income fell 1060.85% to -$36.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$127.4 million, marking a year-over-year decrease of 12.77%. This contributed to the annual value of -$123,627 for FY2022, which is 52.76% up from last year.
  • As of FY2022, ADC Therapeutics' Operating Income stood at -$123,627, which was up 52.76% from -$261,720 recorded in FY2021.
  • In the past 5 years, ADC Therapeutics' Operating Income ranged from a high of -$119,399 in FY2019 and a low of -$261,720 during FY2021.
  • In the last 3 years, ADC Therapeutics' Operating Income had a median value of -$219,263 in 2020 and averaged -$201,537.
  • Its Operating Income has fluctuated over the past 5 years, first crashed by 83.64% in 2020, then skyrocketed by 52.76% in 2022.
  • Yearly analysis of 5 years shows ADC Therapeutics' Operating Income stood at -$125,941 in 2018, then rose by 5.19% to -$119,399 in 2019, then plummeted by 83.64% to -$219,263 in 2020, then dropped by 19.36% to -$261,720 in 2021, then skyrocketed by 52.76% to -$123,627 in 2022.